Related references
Note: Only part of the references are listed.BDNF signaling in context: From synaptic regulation to psychiatric disorders
Camille S. Wang et al.
CELL (2022)
Possible Receptor Mechanisms Underlying Cannabidiol Effects on Addictive-like Behaviors in Experimental Animals
Ewa Galaj et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Acute Stress Induces Cognitive Improvement in the Novel Object Recognition Task by Transiently Modulating Bdnf in the Prefrontal Cortex of Male Rats
Paola Brivio et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2020)
Born to Protect: Leveraging BDNF Against Cognitive Deficit in Alzheimer's Disease
Lucia Caffino et al.
CNS DRUGS (2020)
Chronic Treatment with 50 mg/kg Cannabidiol Improves Cognition and Moderately Reduces A beta(40) Levels in 12-Month-Old Male A beta PPswe/PS1 Delta E9 Transgenic Mice
Georgia Watt et al.
JOURNAL OF ALZHEIMERS DISEASE (2020)
Hypersensitivity to amphetamine's psychomotor and reinforcing effects in serotonin transporter knockout rats: Glutamate in the nucleus accumbens
Lucia Caffino et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
Cannabidiol Induces Rapid and Sustained Antidepressant-Like Effects Through Increased BDNF Signaling and Synaptogenesis in the Prefrontal Cortex
Amanda J. Sales et al.
MOLECULAR NEUROBIOLOGY (2019)
Safety, efficacy, and mechanisms of action of cannabinoids in neurological disorders
Daniel Friedman et al.
LANCET NEUROLOGY (2019)
The pharmacokinetics and the pharmacodynamics of cannabinoids
Catherine J. Lucas et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Probing the endocannabinoid system in healthy volunteers: Cannabidiol alters fronto-striatal resting-state connectivity
Oliver Grimm et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2018)
Simultaneous quantification of cannabinoids tetrahydrocannabinol, cannabidiol and CB1 receptor antagonist in rat plasma: An application to characterize pharmacokinetics after passive cannabis smoke inhalation and co-administration of rimonabant
Abhigyan Ravula et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2018)
Cannabidiol Administered During Peri-Adolescence Prevents Behavioral Abnormalities in an Animal Model of Schizophrenia
Fernanda F. Peres et al.
FRONTIERS IN PHARMACOLOGY (2018)
Ketamine Self-Administration Reduces the Homeostasis of the Glutamate Synapse in the Rat Brain
Lucia Caffino et al.
MOLECULAR NEUROBIOLOGY (2017)
Pharmacology of cannabinoids in the treatment of epilepsy
Tyler E. Gaston et al.
EPILEPSY & BEHAVIOR (2017)
Cannabidiol reduces neuroinflammation and promotes neuroplasticity and functional recovery after brain ischemia
Marco Aurelio Mori et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2017)
Botanicals as Modulators of Neuroplasticity: Focus on BDNF
Enrico Sangiovanni et al.
NEURAL PLASTICITY (2017)
Binding and Signaling Studies Disclose a Potential Allosteric Site for Cannabidiol in Cannabinoid CB2 Receptors
Eva Martinez-Pinilla et al.
FRONTIERS IN PHARMACOLOGY (2017)
Pharmacokinetic and behavioural profile of THC, CBD, and THC plus CBD combination after pulmonary, oral, and subcutaneous administration in rats and confirmation of conversion in vivo of CBD to THC
Tomas Hlozek et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2017)
An update on PPAR activation by cannabinoids
Saoirse Elizabeth O'Sullivan
BRITISH JOURNAL OF PHARMACOLOGY (2016)
The modulation of BDNF expression and signalling dissects the antidepressant from the reinforcing properties of ketamine: Effects of single infusion vs. chronic self-administration in rats
Lucia Caffino et al.
PHARMACOLOGICAL RESEARCH (2016)
ABC transporters P-gp and Bcrp do not limit the brain uptake of the novel antipsychotic and anticonvulsant drug cannabidiol in mice
Natalia Brzozowska et al.
PEERJ (2016)
Human Metabolites of Cannabidiol: A Review on Their Formation, Biological Activity, and Relevance in Therapy
Istvan Ujvary et al.
CANNABIS AND CANNABINOID RESEARCH (2016)
Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor
R. B. Laprairie et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Short-term withdrawal from developmental exposure to cocaine activates the glucocorticoid receptor and alters spine dynamics
Lucia Caffino et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2015)
Glutamate Decarboxylase 67 Deficiency in a Subset of GABAergic Neurons Induces Schizophrenia-Related Phenotypes
Kazuyuki Fujihara et al.
NEUROPSYCHOPHARMACOLOGY (2015)
Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders
Alline Cristina Campos et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2012)
Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ9-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive-compulsive behaviour
Serena Deiana et al.
PSYCHOPHARMACOLOGY (2012)
Repeated stress prevents cocaine-induced activation of BDNF signaling in rat prefrontal cortex
Fabio Fumagalli et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2009)
Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb
Angelo A. Izzo et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Ketamine-induced loss of phenotype of fast-spiking interneurons is mediated by NADPH-oxidase
M. Margarita Behrens et al.
SCIENCE (2007)
Mouse and rat BDNF gene structure and expression revisited
Tamara Aid et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2007)
Hippocampal neurons recycle BDNF for activity-dependent secretion and LTP maintenance
Spartaco Santi et al.
EMBO JOURNAL (2006)
Agonistic properties of cannabidiol at 5-HT1a receptors
EB Russo et al.
NEUROCHEMICAL RESEARCH (2005)
BDNF function in adult synaptic plasticity: The synaptic consolidation hypothesis
CR Bramham et al.
PROGRESS IN NEUROBIOLOGY (2005)
Cortical inhibitory neurons and schizophrenia
DA Lewis et al.
NATURE REVIEWS NEUROSCIENCE (2005)
Activity-dependent modulation of the BDNF receptor TrkB: mechanisms and implications
G Nagappan et al.
TRENDS IN NEUROSCIENCES (2005)
Fluoxetine-induced change in rat brain expression of brain-derived neurotrophic factor varies depending on length of treatment
G De Foubert et al.
NEUROSCIENCE (2004)
Bi-phasic change in BDNF gene expression following antidepressant drug treatment
AL Coppell et al.
NEUROPHARMACOLOGY (2003)
Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide
T Bisogno et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease
C Zuccato et al.
SCIENCE (2001)
Share Paper
